Given our work showing that bone-derived OPN promotes the migration and stem-like behavior of breast cancer cells, we wanted to investigate which cell surface receptors bone-derived OPN uses to influence breast cancer cell properties, and we chose to evaluate the role of CD44 and RGD-dependent integrins in these functions. The gene discussed is CD177; the disease is breast carcinoma.